Digoxin was shown to be dangerous at high levels for atrial fibrillation (Afib) patients in a randomized trial. Meanwhile, another study suggested the benefit of genotyping for better warfarin ...
A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from ...
Digitalis glycosides may be a safe and tolerable addition to optimal guideline medical therapy to reduce worsening heart ...
Drug Therapy Recommendations from the 2005 ACC/AHA Guidelines for Treatment of Chronic Heart Failure
Recommendations for digoxin use in patients with HF have changed only slightly with the 2005 guidelines. [1] The primary change was to reclassify the recommendation for use from Class I, evidence ...
Analyses supporting the use of digitalis glycosides in patients with heart failure were presented in a Late-Breaking Science ...
Older adults with symptomatic HF should be prescribed digoxin in low doses starting at 0.125 mg/d. For persons with HF who are 75 years and older, are women, have renal insufficiency, are receiving ...
Digoxin, a cardiac glycoside derived from the foxglove plant, has been a mainstay of treatment in systolic heart failure and in rate control for atrial fibrillation. By inhibiting the cardiac ...
We wish to report our experience with 72 patients who were treated with acetyldigitoxin. § Forty-nine were given a full digitalizing dose and maintained thereafter on acetyldigitoxin, whereas 23 ...
A low dose of digoxin ensures that people with heart failure are hospitalized and die less frequently. This emerges from three studies led by UMCG cardiologists Dirk Jan van Veldhuisen, Kevin Damman, ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results